SCHEMBL6019399

SCHEMBL6019399

N#CCCNC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)Nc1ccc2c(c1)OCO2

nearest known ligand 0.66

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.66
SMN1; SMN2 Q16637 1/20 0.66
FPR2 P25090 6/20 0.52
FPR1 P21462 3/20 0.52
MMP2 P08253 1/20 0.52
MMP9 P14780 1/20 0.52
MMP8 P22894 1/20 0.52
CTSL P07711 2/20 0.51
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
BRS3 P32247 1/20 0.48
CTSS P25774 1/20 0.48
CTSK P43235 1/20 0.48
MEN1 O00255 1/20 0.47
MAPT P10636 1/20 0.47
ALOX15 P16050 1/20 0.47
KMT2A Q03164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6019973 0.92 MAPK1 (0.71) MAPK1SMN1; SMN2FPR2FPR1MMP2
SCHEMBL6020268 0.85 FPR2 (0.60) FPR2FPR1CTSLBRS3CTSS
SCHEMBL6019996 0.85 FPR2 (0.54) FPR2FPR1CTSLBRS3CTSS
SCHEMBL6020986 0.85 FPR2 (0.56) SMN1; SMN2FPR2FPR1CTSLBRS3
SCHEMBL6020548 0.84 RAB9A (0.56) SMN1; SMN2FPR2CTSLNPC1RAB9A
SCHEMBL6020985 0.84 CTSL (0.48) MAPK1SMN1; SMN2MMP2MMP9MMP8
SCHEMBL6019750 0.82 GOT1 (0.59) SMN1; SMN2FPR2FPR1CTSLBRS3
SCHEMBL6021748 0.82 FPR2 (0.59) FPR2FPR1CTSLBRS3CTSS
SCHEMBL6021038 0.82 FPR2 (0.68) FPR2FPR1MMP2CTSLBRS3
SCHEMBL6019285 0.81 KDM4E (0.55) MAPK1SMN1; SMN2CTSLNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060252813-A1 Apparatus for curing a composite laminate JERINI AG (DE) 2006-11-09 US claimed
EP-1575903-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES Jerini AG (DE) 2005-09-21 EP claimed
WO-2004065353-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES JERINI AG (DE) 2004-08-05 WO claimed
WO-2004056755-A2 COMPOUNDS FOR THE INHIBITION OF NON-PROTEOLYTIC ENZYMES JERENI AG (DE) 2004-07-08 WO claimed
EP-1433778-A1 Use of nitriles as rotamase inhibitors Jerini AG (DE) 2004-06-30 EP claimed
EP-1433779-A1 Use of nitriles as inhibitors of non-proteolytic enzymes Jerini AG (DE) 2004-06-30 EP claimed
US-20060252813-A1 Apparatus for curing a composite laminate JERINI AG (DE) 2006-11-09 US disclosed
EP-1575903-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES Jerini AG (DE) 2005-09-21 EP disclosed
WO-2004065353-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES JERINI AG (DE) 2004-08-05 WO disclosed
EP-1433778-A1 Use of nitriles as rotamase inhibitors Jerini AG (DE) 2004-06-30 EP disclosed
EP-1433779-A1 Use of nitriles as inhibitors of non-proteolytic enzymes Jerini AG (DE) 2004-06-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060252813-A1 Apparatus for curing a composite laminate DHX29, HDHD5, DHRS9 MAPK1 4315/4885SMN1; SMN2 3901/4885FPR2 3247/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.